ENA’s supplied data indicate a strongly weak short-term setup: the price is $0.197892 after a reported 12.05% 24-hour decline, and the 7-day change is also negative at 18.65%. The main counterpoint is that the 30-day change remains positive at 24.74%, so the recent losses have not erased the full-month gain.

There is an inconsistency in the intraday figures: the current price is below the stated 24-hour low of $0.201869, even though the reported high-to-low range is internally consistent at $0.026139. This means the stated range does not contain the current price, so those boundaries should be treated cautiously rather than as a reliable description of the current trading interval.

All five hourly moving averages are above the current price, with the 8 SMA at $0.2161 and the 144 SMA at $0.2362. The listed gaps range from 8.42% to 16.20%, showing that price is substantially below each of these reference levels and supporting a bearish short-term technical reading.

The 1-hour RSI of 15 signals extremely weak recent momentum and is consistent with the sharp decline, but it also indicates an oversold reading that could precede a short-term rebound. That possibility is not confirmed by the other supplied indicators: the 7-day RSI is 43, which is less extreme but still does not show strong momentum.

Momentum is mixed across the measured periods, but the shorter periods lean bearish: ENA is down 18.65% over seven days and 6.43% over 14 days. The 30-day gain of 24.74% is a meaningful counter-signal, though it does not by itself establish that the recent downturn has ended.

Reported 24-hour volume is 435,790,026, and volume relative to market capitalization is 16.43%. These figures show trading activity, but no comparison with prior volume is provided, so they cannot establish whether selling pressure or participation has increased.

ENA is also trading far below its stated all-time high of $1.52, reached on April 11, 2024; the current price is approximately 87% lower. This long-term distance is a clear measure of the drawdown, but the supplied data do not identify a floor or show evidence of a reversal.

Overall, the oversold hourly RSI and positive 30-day performance temper the negative interpretation, but they are outweighed by the steep 24-hour and 7-day declines and the price’s position below every listed hourly moving average. The 7-day RSI of 43 offers little evidence of a strong recovery, while the conflicting intraday range further reduces confidence in near-term price context.

The rating is Sell. The primary evidence is the sharp recent decline combined with price sitting 8.42% to 16.20% below all listed hourly moving averages; the oversold 1-hour RSI and positive 30-day change are relevant counterpoints, but neither outweighs the prevailing short-term weakness in the supplied data.